BBlogFlow

Living With Congestive Heart Failure - Health.com

·Aug 24, 2026
Source: Health.com
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Health.com

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

RSV Vaccination Associated With Survival Benefit in Heart Failure - EMJ

RSV vaccination was associated with substantially lower all-cause mortality among older adults with heart failure in a multicenter, propensity-matched analysis of U. S. electronic health records. Researchers identified adults aged 60 years or older with heart failure and compared outcomes according to respiratory syncytial virus vaccination status. After propensity score matching, 777 vaccinated patients and 777 unvaccinated patients had well-balanced baseline demographic characteristics, comorbidities, and medication use.

EMJ·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·